Your browser doesn't support javascript.
loading
Circulating SARS-CoV-2+ megakaryocytes are associated with severe viral infection in COVID-19.
Fortmann, Seth D; Patton, Michael J; Frey, Blake F; Tipper, Jennifer L; Reddy, Sivani B; Vieira, Cristiano P; Hanumanthu, Vidya Sagar; Sterrett, Sarah; Floyd, Jason L; Prasad, Ram; Zucker, Jeremy D; Crouse, Andrew B; Huls, Forest; Chkheidze, Rati; Li, Peng; Erdmann, Nathaniel B; Harrod, Kevin S; Gaggar, Amit; Goepfert, Paul A; Grant, Maria B; Might, Matthew.
Afiliación
  • Fortmann SD; Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL.
  • Patton MJ; Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, AL.
  • Frey BF; Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL.
  • Tipper JL; Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL.
  • Reddy SB; Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL.
  • Vieira CP; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL.
  • Hanumanthu VS; Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Sterrett S; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL.
  • Floyd JL; Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, AL.
  • Prasad R; Division of Clinical Immunology and Rheumatology, Department of Medicine and Microbiology, University of Alabama at Birmingham, Birmingham, AL.
  • Zucker JD; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Crouse AB; Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, AL.
  • Huls F; Department of Ophthalmology, University of Alabama at Birmingham, Birmingham, AL.
  • Chkheidze R; Biological Sciences Division, Pacific Northwest National Laboratories, Richland, WA.
  • Li P; Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL.
  • Erdmann NB; Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, AL.
  • Harrod KS; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL.
  • Gaggar A; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL.
  • Goepfert PA; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Grant MB; Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Might M; Division of Pulmonary, Allergy and Critical Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Blood Adv ; 7(15): 4200-4214, 2023 08 08.
Article en En | MEDLINE | ID: mdl-36920790

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article